No kidding! I wonder how they are going to ultimately penetrate the market, given that it is so engorged with other drugs that treat the same condition. Some pretty stiff competition out there. They'll really have to work hard at avoiding an impotent marketing campaign.




(Puns all intended here. Sorry, I couldn't help it. )